Agent for improving motor complications or psychiatric symptoms in Parkinson's disease

Details for Australian Patent Application No. 2008330482 (hide)

Owner Asubio Pharma Co., Ltd.

Inventors Koyama, Makoto; Tani, Yoshihiro

Agent Griffith Hack

Pub. Number AU-A-2008330482

PCT Pub. Number WO2009/069828

Priority 2007-311189 30.11.07 JP

Filing date 28 November 2008

Wipo publication date 4 June 2009

International Classifications

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/198 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/069828 Priority application(s): WO2009/069828

9 September 2010 Alteration of Name

  The name of the applicant has been altered to Daiichi Sankyo Company, Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008330495-Medical staple and magazine

2008330433-Production of soluble recombinant protein by pi value control of N-terminal